SOLANA BEACH, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today ...
Deep Brain Stimulation (DBS), a sophisticated neurosurgical therapy, has proved useful in the control of several neurological and movement disorders. The therapy entails the insertion of devices into ...
The platform will be showcased at the American Academy of Neurological Surgeons Annual Meeting in Boston on April 25-28, 2025. SOLANA BEACH, CALIFORNIA / ACCESS Newswire / April 24, 2025 / ClearPoint ...
Medical devices manufacturer Boston Scientific is set to expand its presence in the neurological surgery market, having recently received CE approval for its Vercise Primary Cell Deep Brain ...
Deep brain stimulation (DBS) is a treatment for various neurological conditions such as Parkinson’s disease and obsessive-compulsive disorder. It involves surgically implanting an electrode into your ...
—Deep brain stimulation (DBS) is a safe, well-tolerated, and efficacious treatment for some medically-refractory neuropsychiatric disorders and has been FDA-approved for use in several. Deep brain ...
SOLANA BEACH, Calif., June 01, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain ...
The most important practice learned after introducing multiple early technologies into regulated markets has been that interesting technologies create a starting point; developing a complete solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results